DYNO BCAP

Pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; pharmaceutical preparations, namely, therapeutic pharmaceuticals in the nature of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for the treatment of gene therapy treatable diseases; Pharmaceutical preparations and products in the nature of genetically modified cells for use in the production of pharmaceutical preparations and products, for use in scientific research and pharmaceutical research, and in gene therapy for medical purposes; Drug delivery agents in the nature of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for medical or pharmaceutical purposes; Pharmaceutical preparations for scientific research and pharmaceutical research